Trials / Conditions / Peripheral T-cell Lymphomas (PTCL)
Peripheral T-cell Lymphomas (PTCL)
4 registered clinical trials studyying Peripheral T-cell Lymphomas (PTCL) — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Golidocitinib Combined With GemOx in RR PTCL NCT07279584 | Ruijin Hospital | Phase 2 |
| Terminated | Lenalidomide and Gemcitabine in Relapsed or Refractory Peripheral T-cell Lymphomas NCT05105412 | National Health Research Institutes, Taiwan | Phase 1 / Phase 2 |
| Unknown | Safety and Efficacy of CT125A Cells for Treatment of Relapsed/Refractory CD5+ Hematopoietic Malignancies NCT04767308 | Huazhong University of Science and Technology | EARLY_Phase 1 |
| Active Not Recruiting | Ro Plus CHOEP as First Line Treatment Before HSCT in Young Patients With Nodal Peripheral T-cell Lymphomas NCT02223208 | Fondazione Italiana Linfomi - ETS | Phase 1 / Phase 2 |